<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 5413105
Abstract After injection of glucagon, growth hormone increased to 8.0 ng per milliliter or more in 33 of 34 subjects without apparent pituitary disease. In 21 of 23 patients with pituitary disease the maximum value did not exceed 4.8 ng per milliliter. The glucagon stimulation test is a safe, convenient and reasonably reliable way of testing for growth-hormone deficiency.
Male, Time Factors, Injections, Subcutaneous, Pituitary Diseases, Radioimmunoassay, Glucagon, Injections, Intramuscular, Hypopituitarism, Stimulation, Chemical, Growth Hormone, Humans, Female
Male, Time Factors, Injections, Subcutaneous, Pituitary Diseases, Radioimmunoassay, Glucagon, Injections, Intramuscular, Hypopituitarism, Stimulation, Chemical, Growth Hormone, Humans, Female
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 91 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |